Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(3.28)
# 1,125
Out of 4,412 analysts
132
Total ratings
26.39%
Success rate
8.15%
Average return
Main Sectors:
39 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Initiates: Buy | $9 | $1.78 | +405.62% | 1 | Apr 22, 2024 | |
| ARTL Artelo Biosciences | Maintains: Buy | $5 | $1.34 | +273.16% | 5 | Apr 2, 2024 | |
| ELDN Eledon Pharmaceuticals | Reiterates: Buy | $13 | $2.06 | +531.07% | 5 | Mar 22, 2024 | |
| SENS Senseonics Holdings | Reiterates: Buy | $2 | $0.42 | +381.12% | 6 | Mar 11, 2024 | |
| SAVA Cassava Sciences | Reiterates: Buy | $124 | $22.34 | +455.06% | 11 | Mar 5, 2024 | |
| AEMD Aethlon Medical | Maintains: Buy | $23 → $10 | $1.36 | +635.29% | 4 | Mar 4, 2024 | |
| NVAX Novavax | Maintains: Buy | $35 → $19 | $4.09 | +364.55% | 15 | Mar 1, 2024 | |
| CTXR Citius Pharmaceuticals | Reiterates: Buy | $4 | $0.66 | +501.68% | 7 | Feb 14, 2024 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $4.42 | +375.12% | 8 | Feb 14, 2024 | |
| PHIO Phio Pharmaceuticals | Maintains: Buy | $6 → $4 | $0.68 | +486.51% | 4 | Feb 6, 2024 | |
| ENVB Enveric Biosciences | Initiates: Buy | $10 | $0.90 | +1,017.32% | 1 | Jan 30, 2024 | |
| WINT Windtree Therapeutics | Initiates: Neutral | $1 | $5.23 | -80.88% | 1 | Jan 3, 2024 | |
| MBRX Moleculin Biotech | Initiates: Buy | $45 | $4.63 | +871.92% | 1 | Dec 14, 2023 | |
| HUMA Humacyte | Initiates: Buy | $6 | $3.99 | +50.38% | 1 | Dec 11, 2023 | |
| CADL Candel Therapeutics | Reiterates: Buy | $11 | $6.39 | +72.14% | 3 | Nov 13, 2023 | |
| DYAI Dyadic International | Reiterates: Buy | $6 | $1.49 | +302.68% | 5 | Nov 13, 2023 | |
| GOVX GeoVax Labs | Reiterates: Buy | $120 | $1.42 | +8,350.70% | 9 | Nov 13, 2023 | |
| ARDS Aridis Pharmaceuticals | Reiterates: Buy | $2 | $0.07 | +2,976.92% | 6 | Nov 6, 2023 | |
| CANF Can-Fite BioPharma | Maintains: Buy | $34 → $18 | $1.98 | +809.09% | 3 | Oct 24, 2023 | |
| AYTU Aytu BioPharma | Reiterates: Buy | $20 | $2.90 | +588.63% | 4 | May 31, 2023 | |
| TFFP TFF Pharmaceuticals | Maintains: Buy | $550 → $100 | $2.92 | +3,322.90% | 2 | May 25, 2023 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $20 | $3.54 | +464.97% | 3 | May 25, 2023 | |
| FNCH Finch Therapeutics Group | Reiterates: Buy | $210 | $2.32 | +8,951.72% | 3 | May 12, 2023 | |
| NDRA ENDRA Life Sciences | Reiterates: Buy | $100 → $9 | $0.25 | +3,464.36% | 2 | Mar 31, 2023 | |
| MCRB Seres Therapeutics | Reiterates: Buy | $25 | $0.83 | +2,930.30% | 5 | Mar 8, 2023 | |
| VTVT vTv Therapeutics | Reiterates: Buy | $240 | $26.97 | +790.04% | 4 | Mar 7, 2023 | |
| APM Aptorum Group | Initiates: Buy | $80 | $5.28 | +1,415.15% | 1 | Oct 7, 2022 | |
| POAI Predictive Oncology | Initiates: Buy | n/a | $1.51 | - | 1 | Jun 30, 2021 | |
| TENX Tenax Therapeutics | Initiates: Buy | $8,000 | $3.48 | +229,785.06% | 1 | Dec 29, 2020 | |
| GERN Geron | Maintains: Buy | n/a | $3.79 | - | 1 | Aug 26, 2020 | |
| NSPR InspireMD | Reiterates: Buy | n/a | $2.00 | - | 1 | Mar 11, 2020 | |
| NAVB Navidea Biopharmaceuticals | Reiterates: Buy | n/a | $0.04 | - | 1 | Mar 2, 2020 | |
| ACHV Achieve Life Sciences | Initiates: Buy | n/a | $4.61 | - | 1 | Feb 25, 2020 | |
| CVM CEL-SCI | Initiates: Buy | n/a | $1.44 | - | 1 | Jan 13, 2020 | |
| GALT Galectin Therapeutics | Initiates: Buy | n/a | $3.45 | - | 1 | Oct 6, 2017 | |
| EVOK Evoke Pharma | Initiates: Buy | n/a | $0.46 | - | 1 | Oct 6, 2017 | |
| CYTK Cytokinetics | Initiates: Buy | n/a | $65.34 | - | 1 | Oct 6, 2017 | |
| GLMD Galmed Pharmaceuticals | Initiates: Buy | n/a | $0.39 | - | 1 | Oct 6, 2017 | |
| RDHL RedHill Biopharma | Initiates: Buy | n/a | $0.43 | - | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 22, 2024
Initiates: Buy
Price Target: $9
Current: $1.78
Upside: +405.62%
Artelo Biosciences
Apr 2, 2024
Maintains: Buy
Price Target: $5
Current: $1.34
Upside: +273.16%
Eledon Pharmaceuticals
Mar 22, 2024
Reiterates: Buy
Price Target: $13
Current: $2.06
Upside: +531.07%
Senseonics Holdings
Mar 11, 2024
Reiterates: Buy
Price Target: $2
Current: $0.42
Upside: +381.12%
Cassava Sciences
Mar 5, 2024
Reiterates: Buy
Price Target: $124
Current: $22.34
Upside: +455.06%
Aethlon Medical
Mar 4, 2024
Maintains: Buy
Price Target: $23 → $10
Current: $1.36
Upside: +635.29%
Novavax
Mar 1, 2024
Maintains: Buy
Price Target: $35 → $19
Current: $4.09
Upside: +364.55%
Citius Pharmaceuticals
Feb 14, 2024
Reiterates: Buy
Price Target: $4
Current: $0.66
Upside: +501.68%
Edesa Biotech
Feb 14, 2024
Reiterates: Buy
Price Target: $21
Current: $4.42
Upside: +375.12%
Phio Pharmaceuticals
Feb 6, 2024
Maintains: Buy
Price Target: $6 → $4
Current: $0.68
Upside: +486.51%
Enveric Biosciences
Jan 30, 2024
Initiates: Buy
Price Target: $10
Current: $0.90
Upside: +1,017.32%
Windtree Therapeutics
Jan 3, 2024
Initiates: Neutral
Price Target: $1
Current: $5.23
Upside: -80.88%
Moleculin Biotech
Dec 14, 2023
Initiates: Buy
Price Target: $45
Current: $4.63
Upside: +871.92%
Humacyte
Dec 11, 2023
Initiates: Buy
Price Target: $6
Current: $3.99
Upside: +50.38%
Candel Therapeutics
Nov 13, 2023
Reiterates: Buy
Price Target: $11
Current: $6.39
Upside: +72.14%
Dyadic International
Nov 13, 2023
Reiterates: Buy
Price Target: $6
Current: $1.49
Upside: +302.68%
GeoVax Labs
Nov 13, 2023
Reiterates: Buy
Price Target: $120
Current: $1.42
Upside: +8,350.70%
Aridis Pharmaceuticals
Nov 6, 2023
Reiterates: Buy
Price Target: $2
Current: $0.07
Upside: +2,976.92%
Can-Fite BioPharma
Oct 24, 2023
Maintains: Buy
Price Target: $34 → $18
Current: $1.98
Upside: +809.09%
Aytu BioPharma
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.90
Upside: +588.63%
TFF Pharmaceuticals
May 25, 2023
Maintains: Buy
Price Target: $550 → $100
Current: $2.92
Upside: +3,322.90%
NRx Pharmaceuticals
May 25, 2023
Reiterates: Buy
Price Target: $20
Current: $3.54
Upside: +464.97%
Finch Therapeutics Group
May 12, 2023
Reiterates: Buy
Price Target: $210
Current: $2.32
Upside: +8,951.72%
ENDRA Life Sciences
Mar 31, 2023
Reiterates: Buy
Price Target: $100 → $9
Current: $0.25
Upside: +3,464.36%
Seres Therapeutics
Mar 8, 2023
Reiterates: Buy
Price Target: $25
Current: $0.83
Upside: +2,930.30%
vTv Therapeutics
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $26.97
Upside: +790.04%
Aptorum Group
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $5.28
Upside: +1,415.15%
Predictive Oncology
Jun 30, 2021
Initiates: Buy
Price Target: n/a
Current: $1.51
Upside: -
Tenax Therapeutics
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $3.48
Upside: +229,785.06%
Geron
Aug 26, 2020
Maintains: Buy
Price Target: n/a
Current: $3.79
Upside: -
InspireMD
Mar 11, 2020
Reiterates: Buy
Price Target: n/a
Current: $2.00
Upside: -
Navidea Biopharmaceuticals
Mar 2, 2020
Reiterates: Buy
Price Target: n/a
Current: $0.04
Upside: -
Achieve Life Sciences
Feb 25, 2020
Initiates: Buy
Price Target: n/a
Current: $4.61
Upside: -
CEL-SCI
Jan 13, 2020
Initiates: Buy
Price Target: n/a
Current: $1.44
Upside: -
Galectin Therapeutics
Oct 6, 2017
Initiates: Buy
Price Target: n/a
Current: $3.45
Upside: -
Evoke Pharma
Oct 6, 2017
Initiates: Buy
Price Target: n/a
Current: $0.46
Upside: -
Cytokinetics
Oct 6, 2017
Initiates: Buy
Price Target: n/a
Current: $65.34
Upside: -
Galmed Pharmaceuticals
Oct 6, 2017
Initiates: Buy
Price Target: n/a
Current: $0.39
Upside: -
RedHill Biopharma
Oct 6, 2017
Initiates: Buy
Price Target: n/a
Current: $0.43
Upside: -